The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

October 29, 2019

Study Completion Date

October 29, 2019

Conditions

Chronic Hepatitis C

Interventions

DRUG

HEC110114 tablet

administered orally once daily

DRUG

Placebo Oral Tablet

Placebo will be administered orally at a dose and frequency matched to HEC110114

Trial Locations (1)

The First Hospital of Jilin University, Changchun

All Listed Sponsors

lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY

NCT03903081 - The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter